Publications by authors named "Allison B Wang"

The glucose-responsive insulin (GRI) MK-2640 from Merck was a pioneer in its class to enter the clinical stage, having demonstrated promising responsiveness in in vitro and preclinical studies via a novel competitive clearance mechanism (CCM). The smaller pharmacokinetic response in humans motivates the development of new predictive, computational tools that can improve the design of therapeutics such as GRIs. Herein, we develop and use a new computational model, IMPACT, based on the intersection of human and animal model glucoregulatory systems, to investigate the clinical translatability of CCM GRIs based on existing preclinical and clinical data of MK-2640 and regular human insulin (RHI).

View Article and Find Full Text PDF
Article Synopsis
  • Oxaliplatin (OX) chemotherapy can cause long-lasting problems with how cancer survivors feel and move, but scientists are trying to understand why this happens.
  • Recent studies suggest that it might not just be nerve damage but also issues with how muscles and nerves work together.
  • In a new study, researchers found that the shoulder muscle reflexes in cancer survivors were similar to those of healthy people, which raises questions about how OX affects movement and feeling.
View Article and Find Full Text PDF
Article Synopsis
  • Oxaliplatin (OX) chemotherapy can cause nerve damage that affects how cancer survivors move and sense their bodies, not just in their hands and feet but also in their arms and shoulders.
  • The study tested 13 cancer survivors who received OX and compared them to 13 healthy people to see how well they could perform tasks that required sensing their own body movements, like matching force and maintaining posture.
  • Results showed that cancer survivors had more trouble accurately controlling their arm movements and felt their motor skills were worse, indicating they have issues with proprioception, which is how we sense where our body is in space.
View Article and Find Full Text PDF

Chemotherapy agents used in the standard treatments for many types of cancer are neurotoxic and can lead to lasting sensory and motor symptoms that compromise day-to-day movement functions in cancer survivors. To date, the details of movement disorders associated with chemotherapy are known largely through self-reported symptoms and functional limitations. There are few quantitative studies of specific movement deficits, limiting our understanding of dysfunction, as well as effective assessments and interventions.

View Article and Find Full Text PDF

Muscle force can be generated actively through changes in neural excitation, and passively through externally imposed changes in muscle length. Disease and injury can disrupt force generation, but it can be challenging to separate passive from active contributions to these changes. Ultrasound elastography is a promising tool for characterizing the mechanical properties of muscles and the forces that they generate.

View Article and Find Full Text PDF

We investigated alterations in material properties such as elasticity and viscoelasticity of stroke-affected muscles using ultrasound induced shear waves and mechanical models. We used acoustic radiation force to generate shear waves along fascicles of biceps muscles and measured their propagation velocity. The shear wave data were collected in muscles of 13 hemiplegic stroke survivors under passive conditions at 90°, 120°, and 150° elbow flexion angles.

View Article and Find Full Text PDF

As a result of a brain injury such as stroke, the skeletal muscles may undergo numerous structural and functional alterations. These abnormal changes are linked to muscle weakness, joint contracture, and abnormal muscle tone and eventually, result in motor impairment. A subset of these alterations affects passive muscle stiffness, i.

View Article and Find Full Text PDF